Metastatic leydig cell tumor of the testis report of three cases and review of the literature

Jean L. Grem, H. Ian Robins, Kenneth S. Wilson, Kennedy Gilchrist, Donald L. Trump

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Metastatic Leydig cell carcinomas account for less than 0.2% of all testicular cancers, and may be associated with sex hormone production. Leydig cell carcinoma is relatively refractory to radiotherapy and chemotherapy, and median survival of patients with metastatic disease is less than 2 years. Presented are three cases of metastatic Leydig cell cancer, and a review of the literature pertaining to this rare tumor.

Original languageEnglish (US)
Pages (from-to)2116-2119
Number of pages4
JournalCancer
Volume58
Issue number9
DOIs
StatePublished - Nov 1 1986

Fingerprint

Leydig Cell Tumor
Leydig Cells
Testis
Carcinoma
Testicular Neoplasms
Gonadal Steroid Hormones
Neoplasms
Radiotherapy
Drug Therapy
Survival

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Metastatic leydig cell tumor of the testis report of three cases and review of the literature. / Grem, Jean L.; Robins, H. Ian; Wilson, Kenneth S.; Gilchrist, Kennedy; Trump, Donald L.

In: Cancer, Vol. 58, No. 9, 01.11.1986, p. 2116-2119.

Research output: Contribution to journalArticle

Grem, Jean L. ; Robins, H. Ian ; Wilson, Kenneth S. ; Gilchrist, Kennedy ; Trump, Donald L. / Metastatic leydig cell tumor of the testis report of three cases and review of the literature. In: Cancer. 1986 ; Vol. 58, No. 9. pp. 2116-2119.
@article{3fe478ce32be40d4a5940fa5a1ba2296,
title = "Metastatic leydig cell tumor of the testis report of three cases and review of the literature",
abstract = "Metastatic Leydig cell carcinomas account for less than 0.2{\%} of all testicular cancers, and may be associated with sex hormone production. Leydig cell carcinoma is relatively refractory to radiotherapy and chemotherapy, and median survival of patients with metastatic disease is less than 2 years. Presented are three cases of metastatic Leydig cell cancer, and a review of the literature pertaining to this rare tumor.",
author = "Grem, {Jean L.} and Robins, {H. Ian} and Wilson, {Kenneth S.} and Kennedy Gilchrist and Trump, {Donald L.}",
year = "1986",
month = "11",
day = "1",
doi = "10.1002/1097-0142(19861101)58:9<2116::AID-CNCR2820580925>3.0.CO;2-X",
language = "English (US)",
volume = "58",
pages = "2116--2119",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Metastatic leydig cell tumor of the testis report of three cases and review of the literature

AU - Grem, Jean L.

AU - Robins, H. Ian

AU - Wilson, Kenneth S.

AU - Gilchrist, Kennedy

AU - Trump, Donald L.

PY - 1986/11/1

Y1 - 1986/11/1

N2 - Metastatic Leydig cell carcinomas account for less than 0.2% of all testicular cancers, and may be associated with sex hormone production. Leydig cell carcinoma is relatively refractory to radiotherapy and chemotherapy, and median survival of patients with metastatic disease is less than 2 years. Presented are three cases of metastatic Leydig cell cancer, and a review of the literature pertaining to this rare tumor.

AB - Metastatic Leydig cell carcinomas account for less than 0.2% of all testicular cancers, and may be associated with sex hormone production. Leydig cell carcinoma is relatively refractory to radiotherapy and chemotherapy, and median survival of patients with metastatic disease is less than 2 years. Presented are three cases of metastatic Leydig cell cancer, and a review of the literature pertaining to this rare tumor.

UR - http://www.scopus.com/inward/record.url?scp=0022503143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022503143&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19861101)58:9<2116::AID-CNCR2820580925>3.0.CO;2-X

DO - 10.1002/1097-0142(19861101)58:9<2116::AID-CNCR2820580925>3.0.CO;2-X

M3 - Article

C2 - 3756826

AN - SCOPUS:0022503143

VL - 58

SP - 2116

EP - 2119

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 9

ER -